[{"id":"6cdd3bab-2dd1-4a70-9cc4-0b496a44b196","acronym":"KSH01-TCRT","url":"https://clinicaltrials.gov/study/NCT05539833","created_at":"2022-09-14T18:56:19.768Z","updated_at":"2024-07-02T16:35:51.604Z","phase":"Phase 1","brief_title":"KSH01-TCRT Solid Tumors","source_id_and_acronym":"NCT05539833 - KSH01-TCRT","lead_sponsor":"TCRx Therapeutics Co.Ltd","biomarkers":" HLA-A","pipe":" | ","alterations":" HLA-A*02 • HLA-A2 positive","tags":["HLA-A"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HLA-A*02 • HLA-A2 positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e KSH01"],"overall_status":"Recruiting","enrollment":" Enrollment 50","initiation":"Initiation: 08/19/2022","start_date":" 08/19/2022","primary_txt":" Primary completion: 07/31/2025","primary_completion_date":" 07/31/2025","study_txt":" Completion: 07/31/2027","study_completion_date":" 07/31/2027","last_update_posted":"2023-04-03"}]